SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-20-000163
Filing Date
2020-04-16
Accepted
2020-04-16 16:26:12
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGFOREST BASKETTJOSHUA MAKOWERMOHAMAD H. MAKHZOUMINEA 16 GP, LLCNEA PARTNERS 16, L.P.PAUL WALKERPETER W. SONSINISCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1 nea16-trevi_18392.htm SC 13D/A 426788
  Complete submission text file 0001072613-20-000163.txt   428686
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91005 | Film No.: 20796692
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 16, L.P. (Filed by) CIK: 0001694560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A